Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) Equity Average (2024 - 2025)

Beta Bionics' Equity Average history spans 2 years, with the latest figure at $291.2 million for Q4 2025.

  • For Q4 2025, Equity Average rose 222.81% year-over-year to $291.2 million; the TTM value through Dec 2025 reached $291.2 million, up 222.81%, while the annual FY2025 figure was $21.1 million, 109.42% up from the prior year.
  • Equity Average for Q4 2025 was $291.2 million at Beta Bionics, down from $298.2 million in the prior quarter.
  • Across five years, Equity Average topped out at $307.7 million in Q2 2025 and bottomed at -$237.1 million in Q4 2024.